04 Jan How Automation and Generative AI will Transform Clinical Trials in the Next 1-2 Years

By Venu Mallarapu, Applied Clinical Trials

It’s no surprise that generative artificial intelligence (gen AI) has reached its peak in hype, as we experienced rapid adoption and accelerated interest over the last year. According to the 2023 Gartner Hype Cycle for Artificial Intelligence, we’re at the top of inflated expectations, and as experts have speculated, gen AI’s full potential as a transformative technology has yet to be fully realized.

So, what does this mean for the life sciences industry? We can anticipate seeing several big changes within the industry over the next year. These include:

Gen AI will be the panacea: ChatGPT created shock and awe across the world in 2023 after its initial launch in November 2022, and while we’ve reached the peak of gen AI hype, the practical application of gen AI within the life sciences industry has yet to materialize and have a lasting impact. Over the next year, a lot of mindshare and budgets will be focused on bringing this to fruition for 2024. Read more…